VAERS reports by lot

GSK Varicella/Shingles lot G3T43: VAERS reports

26 VAERS reports list lot G3T43 as a GSK Varicella/Shingles vaccine, received between 2023-03-22 and 2023-12-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2130%
General / Systemic (non-local)1318%
Dermatological (non-injection-site)1115%
Neurological1014%
Musculoskeletal913%
Allergic / Anaphylactic23%
Psychiatric / Neuropsychiatric23%
Cardiac / Cardiovascular11%
Respiratory11%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida3
Pennsylvania2
Wisconsin2
Georgia2
Ohio2
South Carolina2
Colorado2
Arizona2
Oklahoma1
Kentucky1
Michigan1
Tennessee1

Reports by month received

2023-032
2023-048
2023-058
2023-062
2023-072
2023-081
2023-091
2023-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.